Cancer BiologybioRxivPreprint
Neolactotetraosylceramide: A novel non-invasive urinary biomarker for bladder cancer
I. B. Moreira, C. Rossdam, J. Beimdiek…·F. F. R. Buettner
This paper identifies neolactotetraosylceramide (nLc4) as a non-invasive urinary biomarker for bladder cancer, showing higher levels in cancer tissues and urine exosomes with high specificity.
DOI 10.1101/2023.08.08.552442